How it started?
The Kos Foundation reflects the work of a man who is dedicated to making a difference in many lives.
HISTORY
The Kos Foundation was founded in honour of a dedicated group of community members, which includes Zdenko Kos, who in 2011 started completely new research for cancer treatments. The approach was based on the premise that each DNA is unique, so medication should be prepared for individuals or groups of patients with a similar DNA profile, rather than generically as is currently done for cancer treatments.
The KOS Foundation will continue to share their work.
Our Involvement in Numbers
30
COUNTRIES WHERE WE ARE INVOLVED
Austria, Belarus, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and United Kingdom
472 + 192
OUR REGULAR "MAGIC CIRCLE" TEAM
We have 24/7/365 team of 472 scientists, doctors, consultants, surgeons, anaesthetists, lab specialist, special medical professionals, private researchers, pharmacists and freelancers who are working hands to hands with hospitals around the Europe and UK. Daily supported by 192 members of staff of M&M: 64 project & logistic centres managers, 44 transport workers and 20 Pharmacists.
88
CURRENTLY PROGRAMMS IN NUMBERS
Tested & Treated with new medication in the United Kingdom, Switzerland, Germany and Italy:
Brain Cancer: 192,477 Patients
Breast Cancer: 428,166 Patients
Colon/Rectum Cancer: 400,728 Patients
Lung/Bronchus Cancer: 571,206 Patients
Prostate Cancer: 322,714 Patients
Skin Cancer: 210,471 Patients
Funds of the Trustees
INVESTMENT CORPORATION
Owner: The Founder
Annual Report & Financial Statements year ended: 2022
Net Assets: GBP 711,202,600.00